114 related articles for article (PubMed ID: 7612701)
1. Enhancement of interleukin-4-mediated tumor regression in athymic mice by in situ retroviral gene transfer.
Wei MX; Tamiya T; Hurford RK; Boviatsis EJ; Tepper RI; Chiocca EA
Hum Gene Ther; 1995 Apr; 6(4):437-43. PubMed ID: 7612701
[TBL] [Abstract][Full Text] [Related]
2. Transgene inheritance and retroviral infection contribute to the efficiency of gene expression in solid tumors inoculated with retroviral vector producer cells.
Tamiya T; Wei MX; Chase M; Ono Y; Lee F; Breakefield XO; Chiocca EA
Gene Ther; 1995 Oct; 2(8):531-8. PubMed ID: 8593603
[TBL] [Abstract][Full Text] [Related]
3. Effect of in situ retroviral interleukin-4 transfer on established intracranial tumors.
Saleh M; Wiegmans A; Malone Q; Stylli SS; Kaye AH
J Natl Cancer Inst; 1999 Mar; 91(5):438-45. PubMed ID: 10070943
[TBL] [Abstract][Full Text] [Related]
4. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
Ram Z; Culver KW; Walbridge S; Blaese RM; Oldfield EH
Cancer Res; 1993 Jan; 53(1):83-8. PubMed ID: 8380127
[TBL] [Abstract][Full Text] [Related]
5. Local IL-4 delivery enhances immune reactivity to murine tumors: gene therapy in combination with IL-2.
Pippin BA; Rosenstein M; Jacob WF; Chiang Y; Lotze MT
Cancer Gene Ther; 1994 Mar; 1(1):35-42. PubMed ID: 7621236
[TBL] [Abstract][Full Text] [Related]
6. Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins.
Andreansky S; He B; van Cott J; McGhee J; Markert JM; Gillespie GY; Roizman B; Whitley RJ
Gene Ther; 1998 Jan; 5(1):121-30. PubMed ID: 9536273
[TBL] [Abstract][Full Text] [Related]
7. In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors.
Ram Z; Walbridge S; Heiss JD; Culver KW; Blaese RM; Oldfield EH
J Neurosurg; 1994 Mar; 80(3):535-40. PubMed ID: 8113867
[TBL] [Abstract][Full Text] [Related]
8. Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer.
Galipeau J; Li H; Paquin A; Sicilia F; Karpati G; Nalbantoglu J
Cancer Res; 1999 May; 59(10):2384-94. PubMed ID: 10344748
[TBL] [Abstract][Full Text] [Related]
9. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
10. Immunogene therapy as a treatment for malignant brain tumors in young mice.
Glick RP; Lichtor T; Lin H; Tarlock K; Cohen EP
J Neurosurg; 2006 Jul; 105(1 Suppl):65-70. PubMed ID: 16871873
[TBL] [Abstract][Full Text] [Related]
11. Treatment of glioma by engineered interleukin 4-secreting cells.
Yu JS; Wei MX; Chiocca EA; Martuza RL; Tepper RI
Cancer Res; 1993 Jul; 53(13):3125-8. PubMed ID: 8319220
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral administration of recombinant circularly permuted interleukin-4-Pseudomonas exotoxin in patients with high-grade glioma.
Rand RW; Kreitman RJ; Patronas N; Varricchio F; Pastan I; Puri RK
Clin Cancer Res; 2000 Jun; 6(6):2157-65. PubMed ID: 10873064
[TBL] [Abstract][Full Text] [Related]
13. The treatment of established intracranial tumors by in situ retroviral IFN-gamma transfer.
Saleh M; Jonas NK; Wiegmans A; Stylli SS
Gene Ther; 2000 Oct; 7(20):1715-24. PubMed ID: 11083492
[TBL] [Abstract][Full Text] [Related]
14. Experimental tumor therapy in mice using the cyclophosphamide-activating cytochrome P450 2B1 gene.
Wei MX; Tamiya T; Chase M; Boviatsis EJ; Chang TK; Kowall NW; Hochberg FH; Waxman DJ; Breakefield XO; Chiocca EA
Hum Gene Ther; 1994 Aug; 5(8):969-78. PubMed ID: 7948146
[TBL] [Abstract][Full Text] [Related]
15. Effects on brain tumor cell proliferation by an adenovirus vector that bears the interleukin-4 gene.
Wei MX; Li F; Ono Y; Gauldie J; Chiocca EA
J Neurovirol; 1998 Apr; 4(2):237-41. PubMed ID: 9584960
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of TNF-alpha/Bax gene therapy and radiation against C6 glioma xenografts.
Gridley DS; Timiryasova TM; Miller GM; Andres ML; Dutta-Roy R; Bayeta EJ; Fodor I
Technol Cancer Res Treat; 2003 Feb; 2(1):41-50. PubMed ID: 12625753
[TBL] [Abstract][Full Text] [Related]
17. Intracerebral versus subcutaneous immunization with allogeneic fibroblasts genetically engineered to secrete interleukin-2 in the treatment of central nervous system glioma and melanoma.
Glick RP; Lichtor T; Mogharbel A; Taylor CA; Cohen EP
Neurosurgery; 1997 Oct; 41(4):898-906; discussion 906-7. PubMed ID: 9316052
[TBL] [Abstract][Full Text] [Related]
18. Immunogene therapy with interleukin-2-secreting fibroblasts for intracerebrally metastasizing breast cancer in mice.
Deshmukh P; Glick RP; Lichtor T; Moser R; Cohen EP
J Neurosurg; 2001 Feb; 94(2):287-92. PubMed ID: 11213967
[TBL] [Abstract][Full Text] [Related]
19. Eradication of rat malignant gliomas by retroviral-mediated, in vivo delivery of the interleukin 4 gene.
Benedetti S; Bruzzone MG; Pollo B; DiMeco F; Magrassi L; Pirola B; Cirenei N; Colombo MP; Finocchiaro G
Cancer Res; 1999 Feb; 59(3):645-52. PubMed ID: 9973213
[TBL] [Abstract][Full Text] [Related]
20. Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells.
Li S; Tokuyama T; Yamamoto J; Koide M; Yokota N; Namba H
Cancer Gene Ther; 2005 Jul; 12(7):600-7. PubMed ID: 15775995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
